{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:34:47Z","timestamp":1770467687666,"version":"3.49.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Despite having negative lymph node (N0) status, thyroid cancer (TC) patients can still experience distant metastasis (DM), which significantly impacts their survival. This study aimed to investigate the prognostic factors for DM in TC patients (N0) and develop a predictive nomogram model for analyzing the prognosis of TC N0 patients with DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data collected from the Surveillance, Epidemiology, and End Results (SEER) database for 18,504 TC patients (N0) between 2004 and 2015 were analyzed. Univariate and multivariate analyses were used to identify independent prognostic factors for DM in TC N0. These independent factors were used to build a nomogram model to predict overall survival (OS) at 1, 3, and 5 years for TC patients (N0) with DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and conclusion<\/jats:title><jats:p>This study examined the clinicopathological features associated with the risk and prognosis of DM in TC patients (N0), and successfully established and validated a nomogram capable of predicting OS in individual patients with DM. The nomogram is highly useful for the timely identification of TC patients (N0) at high risk of DM by physicians, enabling individualized survival evaluations and treatment for TC patients with DM (N0).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1523785","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:12:22Z","timestamp":1739769142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A prognostic nomogram for distant metastasis in thyroid cancer patients without lymph node metastasis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoqing","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daixing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0687","article-title":"Risk haplotypes uniquely associated with radioiodine-refractory thyroid cancer patients of high African ancestry","volume":"29","author":"Hurst","year":"2019","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0263-x","article-title":"Geographic influences in the global rise of thyroid cancer","volume":"16","author":"Kim","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30201","article-title":"The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients","volume":"122","author":"Lubitz","year":"2016","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"18745","DOI":"10.1038\/s41598-019-55370-w","article-title":"Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic spread is an early step in breast cancer","volume":"13","author":"Husemann","year":"2008","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1370","article-title":"Mechanisms of cancer cell dormancy\u2013another hallmark of cancer","volume":"75","author":"Yeh","year":"2015","journal-title":"Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.08.003","article-title":"Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer","volume":"8","author":"Fuhrmann","year":"2005","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.03.002","article-title":"Cancer stem cells and metastasis","volume":"22","author":"Sampieri","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3678","article-title":"Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications","volume":"73","author":"Valent","year":"2013","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052016-100256","article-title":"Circulating tumor cells: fluid surrogates of solid tumors","volume":"12","author":"Thiele","year":"2017","journal-title":"Annu Rev Pathol: Mech Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.800639","article-title":"Nomogram individually predicts the risk for distant metastasis and prognosis value in female differentiated thyroid cancer patients: A SEER-based study","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09567-3","article-title":"Construction and validation of a nomogram based on the log odds of positive lymph nodes to predict the prognosis of medullary thyroid carcinoma after surgery","volume":"28","author":"Tang","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11911-8","article-title":"Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort","volume":"29","author":"Huang","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B16","unstructured":""},{"key":"B17","unstructured":"Surveillance E, and End Results Program\n          \n          \n          Cancer stat facts: thyroid cancer\n          \n          2022"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1515\/cclm.2002.083","article-title":"High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer","volume":"40","author":"Giovanella","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/nejm199801293380506","article-title":"Papillary and follicular thyroid carcinoma","volume":"338","author":"Schlumberger","year":"1998","journal-title":"New Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31814697d9","article-title":"Extent of surgery affects survival for papillary thyroid cancer","volume":"246","author":"Bilimoria","year":"2007","journal-title":"Ann Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1070-1","article-title":"A phase II study of sunitinib in patients with recurrent and\/or metastatic non-nasopharyngeal head and neck cancer","volume":"65","author":"Fountzilas","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMc1503150","article-title":"Lenvatinib in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10180","article-title":"Treatment outcomes of differentiated thyroid cancer with distant metastasis improve by tyrosine kinase inhibitors","volume":"17","author":"Iwasaki","year":"2019","journal-title":"Oncol Lett"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944","article-title":"American thyroid association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0513","article-title":"Effect of tumor size and minimal extrathyroidal extension in patients with differentiated thyroid cancer","volume":"28","author":"Tam","year":"2018","journal-title":"Thyroid"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer","volume":"98","author":"Nikiforova","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.0825","article-title":"Molecular-directed treatment of differentiated thyroid cancer: advances in diagnosis and treatment","volume":"151","author":"Yip","year":"2016","journal-title":"JAMA Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.5858\/133.5.683","article-title":"Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin","volume":"133","author":"Ghossein","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2616","article-title":"H\u00fcrthle cell carcinoma: a critical histopathologic appraisal","volume":"19","author":"Stojadinovic","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1523785\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:12:24Z","timestamp":1739769144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1523785\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":33,"alternative-id":["10.3389\/fendo.2025.1523785"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1523785","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"article-number":"1523785"}}